213 related articles for article (PubMed ID: 30539525)
1. Origins of Suicide Gene Therapy.
Düzgüneş N
Methods Mol Biol; 2019; 1895():1-9. PubMed ID: 30539525
[TBL] [Abstract][Full Text] [Related]
2. Osteonectin Promoter-Mediated Suicide Gene Therapy of Prostate Cancer.
Hsiao WC; Sung SY; Chung LWK; Hsieh CL
Methods Mol Biol; 2019; 1895():27-42. PubMed ID: 30539527
[TBL] [Abstract][Full Text] [Related]
3. Suicide Gene Therapy of Oral Squamous Cell Carcinoma and Cervical Carcinoma In Vitro.
Düzgüneş N; Cheung J; Konopka K
Methods Mol Biol; 2019; 1895():177-184. PubMed ID: 30539538
[TBL] [Abstract][Full Text] [Related]
4. Suicide Gene Therapy for Oral Squamous Cell Carcinoma.
Faneca H; Düzgüneş N; Pedroso de Lima MC
Methods Mol Biol; 2019; 1895():43-55. PubMed ID: 30539528
[TBL] [Abstract][Full Text] [Related]
5. Cancer Suicide Gene Therapy with TK.007.
Hossain JA; Riecken K; Miletic H; Fehse B
Methods Mol Biol; 2019; 1895():11-26. PubMed ID: 30539526
[TBL] [Abstract][Full Text] [Related]
6. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
[TBL] [Abstract][Full Text] [Related]
7. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
[TBL] [Abstract][Full Text] [Related]
8. Stem cell based cancer gene therapy.
Cihova M; Altanerova V; Altaner C
Mol Pharm; 2011 Oct; 8(5):1480-7. PubMed ID: 21755953
[TBL] [Abstract][Full Text] [Related]
9. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
[TBL] [Abstract][Full Text] [Related]
10. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication.
Mesnil M; Yamasaki H
Cancer Res; 2000 Aug; 60(15):3989-99. PubMed ID: 10945596
[TBL] [Abstract][Full Text] [Related]
11. Adenovirally delivered enzyme prodrug therapy with herpes simplex virus-thymidine kinase in composite tissue free flaps shows therapeutic efficacy in rat models of glioma.
Seth R; Khan AA; Pencavel TD; Wilkinson MJ; Kyula JN; Simpson G; Pandha H; Melcher A; Vile R; Harris PA; Harrington KJ
Plast Reconstr Surg; 2015 Feb; 135(2):475-487. PubMed ID: 25626794
[TBL] [Abstract][Full Text] [Related]
12. Advances in imaging gene-directed enzyme prodrug therapy.
Bhaumik S
Curr Pharm Biotechnol; 2011 Apr; 12(4):497-507. PubMed ID: 21342105
[TBL] [Abstract][Full Text] [Related]
13. Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies.
Aghi M; Kramm CM; Chou TC; Breakefield XO; Chiocca EA
J Natl Cancer Inst; 1998 Mar; 90(5):370-80. PubMed ID: 9498487
[TBL] [Abstract][Full Text] [Related]
14. Treatment of thyroid carcinoma cells with four different suicide gene/prodrug combinations in vitro.
Nishihara E; Nagayama Y; Narimatsu M; Namba H; Watanabe M; Niwa M; Yamashita S
Anticancer Res; 1998; 18(3A):1521-5. PubMed ID: 9673364
[TBL] [Abstract][Full Text] [Related]
15. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.
Hajri A; Wack S; Lehn P; Vigneron JP; Lehn JM; Marescaux J; Aprahamian M
Cancer Gene Ther; 2004 Jan; 11(1):16-27. PubMed ID: 14681723
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer.
Freytag SO; Stricker H; Pegg J; Paielli D; Pradhan DG; Peabody J; DePeralta-Venturina M; Xia X; Brown S; Lu M; Kim JH
Cancer Res; 2003 Nov; 63(21):7497-506. PubMed ID: 14612551
[TBL] [Abstract][Full Text] [Related]
17. Tumor sensitization to purine analogs by E. coli PNP.
Curlee KV; Parker WB; Sorscher EJ
Methods Mol Med; 2004; 90():223-45. PubMed ID: 14657566
[No Abstract] [Full Text] [Related]
18. Gene therapy of cancer: activation of nucleoside prodrugs with E. coli purine nucleoside phosphorylase.
Secrist JA; Parker WB; Allan PW; Bennett LL; Waud WR; Truss JW; Fowler AT; Montgomery JA; Ealick SE; Wells AH; Gillespie GY; Gadi VK; Sorscher EJ
Nucleosides Nucleotides; 1999; 18(4-5):745-57. PubMed ID: 10432677
[TBL] [Abstract][Full Text] [Related]
19. Cytosine deaminase versus thymidine kinase: a comparison of the antitumor activity.
Corban-Wilhelm H; Becker G; Bauder-Wüst U; Greulich D; Debus J
Clin Exp Med; 2003 Nov; 3(3):150-6. PubMed ID: 14648229
[TBL] [Abstract][Full Text] [Related]
20. Killing effect of the herpes simplex virus thymidine kinase/ganciclovir enzyme/prodrug system on human nasopharyngeal carcinoma cells.
Tang Y; Li J; Zhao S; Liu J
J Int Med Res; 2007; 35(4):433-41. PubMed ID: 17697519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
